glams-2025

Announcing the launch of GLAMS AMS 6.0 – Our latest and most powerful Artwork Management System release to date.

adriana.medina@perigord-as.com (Adriana Medina) — Wed, 23 Apr 2025 11:14:19 GMT

Designed specifically for the Life Science Industry, this version of our GLAMS AMS solution ensures that Perigord maintains its leadership position as the go-to provider of the world's leading Life Science and Pharmaceutical Artwork Management Platform.

Dublin, Ireland – Perigord is proud to announce the launch of GLAMS AMS 6 , the latest evolution of its Artwork Management System (AMS) built specifically for the Life Science industry. GLAMS AMS 6 is a cornerstone of our Global Life Sciences Automation Management System .

Featuring the most advanced and cutting-edge capabilities, GLAMS AMS 6 helps Life Science companies address their most pressing challenges and needs in artwork creation, approval, and compliance within the industry today. With the adoption of GLAMS AMS 6, our clients can accelerate efficiency across the artwork production and approval process, significantly reducing their time-to-market.

With the GLAMS AMS 6 solution, Life Science organisations can optimise processes and manage artwork production globally in a seamless and unified system.

Key GLAMS AMS 6 Enhancements Include:

State-of-the-Art UX Upgrades: Intuitive interface designed for faster, more accessible, and easier navigation and searching across the platform, now complemented by an AI assistant tool for improved user support.
Faster Response Times: Enhanced performance for quicker processing and a smoother user experience.
Strengthened BI Reporting: Advanced reporting capabilities providing comprehensive insights into every stage of the artwork lifecycle.
Expanded Stamping Capabilities: Flexible, configurable options for document approval stamps to ensure clarity and compliance.
Upgraded Linked Workflow Creation and Integration: Seamless creation and management of complex hierarchical workflows for more accurate project tracking and efficiency.
File View and Navigation without Download: Enables quicker, more efficient interaction with artwork files, reducing the need for downloads.
Real-Time Task Dependency Refinements: Improved visibility into task interdependencies, promoting better collaboration and reducing bottlenecks.
Automated Decision-Based Workflow Advancements: Automation of workflow paths based on data and decisions made as the process progresses, increasing efficiency and accuracy in the critical path without manual intervention.
Integrated Subscription-Based Notification Centre: Real-time, on-screen notifications allowing more efficient interaction with workflows.
Enhanced User Permission Administration: Offering efficiencies to handle whole-user base access permissions in just a few clicks.

GLAMS AMS 6 builds upon the foundation of previous releases while introducing new advanced features that set it apart from other AMS solutions. GLAMS AMS 6 helps companies enhance productivity, reduce artwork approval time, and maintain regulatory compliance – ensuring a faster and more efficient time-to-market for critical products.

" The launch of GLAMS AMS 6 is a major milestone for us, further solidifying our position as the industry’s leading Artwork Management solution provider ,” says Suzanne Ivory, Chief Operations Officer, Perigord . “ Through close collaboration with some of the world’s top Pharmaceutical and Life Science organisations, we've developed a solution that makes workflows more efficient, reduces delays in packaging development, and helps teams manage and approve artwork with speed and full compliance. "

Sam Cole, Director of Client Services, Perigord , adds, “ The new enhancements in GLAMS AMS 6 have been designed to offer a truly automated, scalable, and compliant solution that integrates seamlessly with existing systems, optimising key processes at every stage of the packaging and labelling workflow. These improvements are a direct result of our ongoing efforts to support Life Science organisations in managing more complex global regulatory requirements while improving operational efficiency. ”

About GLAMS AMS

GLAMS AMS is the only Artwork Management System developed specifically for the Life Science industry, addressing the unique challenges associated with artwork creation, approvals, and regulatory compliance. By leveraging automated workflows, advanced integration with existing business systems, and powerful reporting tools, GLAMS AMS helps clients in the Life Sciences industry minimise risk, streamline approval cycles, and accelerate product launches across multiple regulatory regions simultaneously.

Available now, GLAMS AMS 6 is ready to help businesses evolve their artwork and labelling management with greater speed, security, and compliance.

Request a demo at: www.GLAMS.com

For more information contact your GLAMS Account Manager or:

Mark Ennis

Global Business Development Director

mark.ennis@perigord-as.com

Perigord Life Science Solutions

Unit 1, Lyncon Court IDA Business & Technology Park

Snugborough Road, Blanchardstown

Dublin, D15 N283, Ireland

mediarelations@perigord-as.com

Tel: +353 1 440 3222

www.GLAMS.com

Advanced Artwork and Labelling Production Analytics White Paper

gary.orr@perigord-as.com (Gary Orr) — Tue, 01 Apr 2025 13:54:00 GMT

Advanced Artwork and Labelling Production Analytics White Paper

Pharmaceutical Artwork Departments can accelerate business impact
with Advanced Artwork and Labelling Production Analytics (AALPA)

As global healthcare markets become more cost constrained, pharmaceutical companies are leveraging the data generated across all aspects of the supply chain to drive decision making and gain competitive advantage over their rivals.

It has been estimated that operating efficiencies achieved by enhancing processes or eliminating inefficiencies identified using Advanced Artwork and Labelling Production Analytics (AALPA) can range from between 50% to 70%. This presents a concrete opportunity for pharmaceutical companies to increase productivity, reinforce compliance, accelerate time-to-market and remove unwanted waste from the supply chain.

Read our guide to find out how ALPA can assist Pharmaceutical Artwork Departments accelerate business impact:

Best Practice White Paper for Remote Auditing in a GMP Environment

adriana.medina@perigord-as.com (Adriana Medina) — Tue, 01 Apr 2025 12:01:06 GMT

Best Practice White Paper for Remote Auditing in a GMP Environment

Since 2020, auditing as we know it has changed. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.

Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper

gary.orr@perigord-as.com (Gary Orr) — Mon, 01 Apr 2024 18:13:08 GMT

Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper

Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper

For over two decades, organisations around the world have been using business process service (BPS) organisations to improve service delivery and drive cost optimisation across their businesses. The pharmaceutical industry is one of the most highly regulated industries in the world and one in which there is no room for error. Increasingly pharmaceutical organisations are outsourcing many downstream commercial functions, including those involving and associated with the artwork and labelling process. Outsourcing these functions and realising the full potential of subject matter experts can deliver economies of scale, increased flexibility, shorter lead times and remove the challenges of recruiting, training, and retaining teams.

Read our guide to find out the why, how, and what to look for when considering outsourcing your pharmaceutical packaging artwork, labelling and associated functions: